Metal-trained endophyte biocontrol agents for disease suppression in metal-contaminated soils

Overview

This research proposes a novel biocontrol strategy that uses metal-tolerant fungal endophytes, "trained" through controlled exposure to high concentrations of heavy metals such as lead, aluminum, and chromium, to protect crops grown in metal-contaminated soils. Prior work showed that untrained endophytes provided only partial disease suppression, with disease severity ranging from 56–78% compared to 67–89% in untreated controls. The central hypothesis is that pre-conditioning these beneficial microorganisms will significantly enhance their ability to suppress plant diseases under metal-stressed conditions, offering a sustainable alternative to chemical fungicides for crops affected by pathogens such as Ganoderma boninense in oil palm cultivation.

Technical specifications

Core approach:

• Endophyte strains are "trained" by gradual exposure to metal concentrations up to 6,000 ppm of Pb, Al, or Cr to induce metal tolerance
• Trained isolates are evaluated for tolerance index and growth performance post-induction
• Inoculated onto host plants grown in metal-treated soils to assess disease suppression
• Disease outcomes measured through disease incidence (DI), disease severity (DS), and symptom progression tracking

Key differentiator:

• Addresses a documented limitation of conventional biocontrol agents that lose efficacy in metal-contaminated environments
• Builds on existing baseline data demonstrating endophyte-mediated disease delay, now seeking to amplify that protective effect through tolerance training

Technology readiness level

The research is at an early-to-mid stage of laboratory validation. Proof-of-concept data exists showing that untrained endophytes can delay disease symptom onset, though suppression levels remain insufficient. The proposed work focuses on optimizing the training protocol and validating improved performance in planta. The technology requires further controlled greenhouse and field trials before commercial deployment. The research team seeks financial support, knowledge exchange, and collaborative expertise to advance validation and scale development.